ISB News

ISB Spotlight: Lisa Iype

Dr. Lisa Iype (Ilya Shmulevich group) has been promoted to Senior Bioinformatics Scientist. She has experience in biochemistry, software and website development, and data analysis. She works with high-dimensional cancer data sets and looks for significant patterns which may provide insight into cancer development and progression. Dr. Shmulevich commented: “Lisa has made major contributions to The Cancer Genome Atlas project through her participation in tumor working groups, including thyroid carcinoma and prostate cancer, and her leadership role in the development of Regulome Explorer as a research tool in cancer genomics.” Congratulations to Lisa.

Recent Articles

  • 2024 Year in Review

    Reflecting on the past year, ISB has a lot to celebrate: groundbreaking research published in leading scientific journals, well-earned promotions, widespread media coverage, and more. Enjoy our year-in-review roundup highlighting some of the important, interesting, and impactful highlights of 2024.

  • My Digital Gut

    ISB Named Winner of 2024-2025 Amazon Web Services IMAGINE Grant for Nonprofits

    ISB has been selected as a winner of the 2024 Amazon Web Services (AWS) IMAGINE Grant. The grant will support ISB’s continued development of My Digital Gut, an online decision-support platform that will help make microbiome-informed nutrition and healthcare personalized, predictive, and preventive. 

  • ISB-Developed MetaboCore Offers Precision Cancer Care Faster Than Ever 

    ISB Associate Professor Dr. Wei Wei and his colleagues have developed a promising new companion diagnostic tool called MetaboCore to help physicians quickly select the most effective systemic therapy for each cancer patient.